Corometrics 120 Series Maternal/Fetal Monitor
by GE Medical Systems Information Technologies
PMA P000016510(k) K032252
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k) 510(k) | NumberK032252 | Date21 Aug 2003 | StatusActive |
| United States | FDA PMA PMA | NumberP000016 | Date9 Feb 2001 | StatusWithdrawn |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k), FDA PMA Active
Specification
- Full name
- Corometrics Model 120 Series Maternal/Fetal Monitor W/Integrated Fetal Pulse Oximetry
- Trade Name
- Corometrics 120F Series Maternal/Fetal Monitor
- Generic Name
- Oximeter, fetal pulse
- PMA Number
- 510(k) Number
- FDA Product Code
- HGM
- Models / Variants
- Device Class
- Class II
- Regulation
- 21 CFR Part 884.2740
- Advisory Committee
- Obstetrics/Gynecology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Corometrics 120 Series Maternal/Fetal Monitor is a medical system designed for continuous intrapartum fetal oxygen saturation monitoring. It functions as an adjunct to fetal heart rate monitoring, specifically intended for use when a nonreassuring fetal heart rate pattern is identified.
This system is designed for use on a singleton fetus in vertex presentation with a gestational age of 36 weeks or greater. It is intended for clinical application only after maternal membranes have ruptured. The system integrates fetal oxygen saturation monitoring, a fetal patient module, and the Nellcor OxiFirst FS14 sensor.
Other devices from GE Medical Systems Information Technologies, Inc.
See all devices from GE Medical Systems Information Technologies, Inc. →
Questions
AI-generated answers, 18 Sep 2026
What is the primary clinical use of the Corometrics 120 Series?
The device is used for continuous intrapartum fetal oxygen saturation monitoring. It serves as an adjunct to fetal heart rate monitoring when a nonreassuring heart rate pattern is detected.
Are there specific patient requirements for using this monitor?
Yes, the monitor is indicated for use only on a singleton fetus in vertex presentation with a gestational age of 36 weeks or greater, and only after the maternal membranes have ruptured.
What components are included in the monitoring system?
The system includes the maternal/fetal monitor, a fetal patient module, and the Nellcor OxiFirst FS14 sensor for oxygen saturation monitoring.